The Bank of Bahrain and Kuwait (BBK), a premier retail and commercial bank in the Kingdom, has announced an exciting lineup ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced that it will present at the following healthcare conferences: Citi's 2025 Unplugged Medtech and Life ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into ...

Scott Bertram, a director at Becton Dickinson & Co. (NYSE:BDX), recently sold 700 shares of the company's common stock, according to a recent filing with the Securities and Exchange Commission. The ...

Shares of Becton Dickinson & Co. BDX slipped 1.60% to $225.85 Wednesday, on what proved to be an all-around rough trading ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Noguchi Memorial Institute for Medical Research (NMIMR) has commissioned the FACS Discover S8 Cell Sorter, the most advanced of its kind ...

BD recently issued a medical device correction later related to its Bard subsidiary's Rotarex atherectomy system.

The FDA is getting the word out on a high-risk issue related to artery-clearing catheters from BD’s Bard Peripheral Vascular ...

According to the company, medical essentials and interventional lead the medical technology unit's business lines, bringing ...